Encyclopedia

  • Amastatin potentiates the behavioral effects of vasopressin and oxytocin in mice
  • Add time:07/23/2019         Source:sciencedirect.com

    Vasopressin and oxytocin cause behavioral excitation after intracerebroventricular injection in mice. This effect is short-lasting, suggesting that the peptides are rapidly inactivated in the brain. Co-injection of microgram amounts of amastatin, an aminopeptidase inhibitor, prolonged the effect of both vasopressin and oxytocin. Amastatin did not induce large vasopressin-like behavioral effects by itself, nor did it significantly potentiate the action of l-deamino[1.6-dicarba, 8-arginine] vasopressin (Asu-AVP), an analog that lacks the N-terminal amino group. The effect of Asu-AVP, but not that of vasopressin, was potentiated by phosphoramidon, an inhibitor of neutral metalloendopeptidase (“enkephalinase A”). These results support previous suggestions that vasopressin and oxytocin are inactivated mainly by aminopeptidase action following intracerebroventricular injection.

    We also recommend Trading Suppliers and Manufacturers of DEAMINO-DICARBA-OXYTOCIN (cas 14317-68-1). Pls Click Website Link as below: cas 14317-68-1 suppliers


    Prev:Pharmacology of cyclic analogues of deamino-oxytocin not containing a disulphide bond (carba analogues)
    Next: Homocysteine and lipid metabolism in atherogenesis: effect of the homocysteine thiolactonyl derivatives, thioretinaco and thioretinamide)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View